Mediators such as angiotensin II, cytokines, sheer stress, and advanced glycation end-products, and conditions such as diabetes mellitus, hypertension and dyslipidemia, upregulate LOX-1 [12,13,14]. This evidence concerns the gene OLR1 and hypertensive disorder.